Efficacy News and Research

RSS

Combination of multi-specificity and antibody avidity enhances protection against SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, an international team of researchers leveraged the human light chain apoferritin protomer-derived MULTI-specific, multi-Affinity antibody (Multabody, MB) platform for the generation of broad and potent SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)-neutralizing antibodies (Abs).

27 Oct 2022

An unprecedented list of health-threatening fungi released by the WHO

The WHO fungal priority pathogens list ranks pathogens that pose a serious risk of morbidity and mortality in humans.

27 Oct 2022

UC San Diego participates in national trial to assess potential treatment for human monkeypox

The University of California San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox.

27 Oct 2022

Study shows potential for eliminating surgery in a small subset of breast cancer patients

Researchers evaluate the efficacy of radiotherapy in patients with early-stage HER2-positive breast cancer or TNBC after neoadjuvant systemic therapy.

27 Oct 2022

Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants

Researchers comparatively evaluated the neutralization antibody titers for SARS-CoV-2 Omicron VOC subvariants BA.1, BA.2, BA.4/5 among individuals with ancestral B.1 strain infections, vaccinated individuals, or with hybrid immunity from breakthrough infections and vaccinations with Delta or Gamma VOCs.

27 Oct 2022

Monoclonal antibodies generated from COVID-19-recovered individuals shed light on the molecular basis of SARS-CoV-2 Omicron variant immune evasion

Researchers reported three human monoclonal antibodies generated from COVID-19-recovered individuals during the initial wave of the pandemic in India.

27 Oct 2022

Some healthcare workers vaccinated against COVID-19 show unexpectedly low responses to immunizations

A subset of healthcare workers vaccinated against COVID-19 had unexpectedly low responses to the immunizations, according to Cedars-Sinai investigators.

27 Oct 2022

Early temperamental and neurocognitive risk factors may play a role in future anxiety, depression

A recent imaging study led by a scientist at The University of Texas at Dallas has identified early risk factors linked to children's temperament and a neural process that could foretell whether an individual might develop depression and anxiety in adolescence and early adulthood.

26 Oct 2022

Using magnetic bacteria to fight cancerous tumors

Researchers at ETH Zurich are planning to use magnetic bacteria to fight cancerous tumors. They have now found a way for these microorganisms to effectively cross blood vessel walls and subsequently colonize a tumor.

26 Oct 2022

What is the efficacy of RT-PCR assays for detection of SARS-CoV-2 in human semen?

A new study aimed to develop a standardized protocol for SARS-CoV-2 RNA detection in semen fractions used for assisted reproductive technology.

26 Oct 2022

What is the association of self-reported post-vaccination symptoms with anti–SARS-CoV-2 antibody response?

Researchers investigated the association of symptoms after COVID-19 vaccination with antibody responses against SARS-CoV-2.

26 Oct 2022

How important is sterilizing immunity in protection against SARS-CoV-2?

The authors discussed the underlying principles of sterilizing immunity and its importance in protecting individuals against SARS-CoV-2 reinfections during the COVID-19 pandemic.

26 Oct 2022

25 years on, varicella vaccination reports impressive success in the USA

New research suggests that 25 years on, varicella vaccination continues to report impressive success in the USA.

26 Oct 2022

A review of emerging pediatric respiratory viruses

Respiratory viruses continue to be a leading cause of childhood morbidity and mortality.

26 Oct 2022

Exploring new therapeutic targets and biomarkers for neurodegenerative disorders

In this interview, Dr. Shebna Massey discusses neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and more. She also discusses and explores new therapeutic targets and biomarkers for these diseases.

From Sino Biological Inc. 26 Oct 2022

Researchers identify specific T cell required to bolster vaccine immunity against fungal pneumonia

Researchers at the University of Illinois College of Veterinary Medicine have demonstrated in a mouse model that a specific type of T cell, one of the body's potent immune defenses, produces cytokines that are necessary for the body to acquire immunity against fungal pathogens.

25 Oct 2022

Efficacy News and Research

Combination of multi-specificity and antibody avidity enhances protection against SARS-CoV-2

An unprecedented list of health-threatening fungi released by the WHO

UC San Diego participates in national trial to assess potential treatment for human monkeypox

Study shows potential for eliminating surgery in a small subset of breast cancer patients

Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants

Monoclonal antibodies generated from COVID-19-recovered individuals shed light on the molecular basis of SARS-CoV-2 Omicron variant immune evasion

Some healthcare workers vaccinated against COVID-19 show unexpectedly low responses to immunizations

Early temperamental and neurocognitive risk factors may play a role in future anxiety, depression

Using magnetic bacteria to fight cancerous tumors

What is the efficacy of RT-PCR assays for detection of SARS-CoV-2 in human semen?

What is the association of self-reported post-vaccination symptoms with anti–SARS-CoV-2 antibody response?

How important is sterilizing immunity in protection against SARS-CoV-2?

25 years on, varicella vaccination reports impressive success in the USA

A review of emerging pediatric respiratory viruses

Exploring new therapeutic targets and biomarkers for neurodegenerative disorders

Researchers identify specific T cell required to bolster vaccine immunity against fungal pneumonia

Researchers set sights on a new therapeutic target for aggressive breast cancer

Is there a difference in the risk of hospital admission between BA.1 and BA.2 cases treated with Sotrovimab?

Ivermectin is ineffective in non-severe COVID-19 patients according to new study

Researchers design a COVID-19 vaccine construct using hybrid SARS-CoV-2 spike protein and nucleocapsid protein peptides

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News